A detailed history of Catalina Capital Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Catalina Capital Group, LLC holds 5,904 shares of BSX stock, worth $531,360. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,904
Previous 5,578 5.84%
Holding current value
$531,360
Previous $430 Million 15.18%
% of portfolio
0.17%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$72.96 - $84.0 $23,784 - $27,384
326 Added 5.84%
5,904 $495 Million
Q2 2024

Jul 24, 2024

BUY
$67.33 - $77.71 $11,378 - $13,132
169 Added 3.12%
5,578 $430 Million
Q1 2024

May 03, 2024

BUY
$57.6 - $68.62 $311,558 - $371,165
5,409 New
5,409 $370 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Catalina Capital Group, LLC Portfolio

Follow Catalina Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalina Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalina Capital Group, LLC with notifications on news.